Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Ruschin

Showing results (81-90 of 107) with videos related to

Pageof 11
Sort By:
Physics and Imaging in Radiation Oncology|December 16, 2025
Magnetic resonance imaging-guided linear accelerator arterial spin labelling reveals dynamics of highly perfused non-enhancing glioblastoma during radiotherapyLiam S P Lawrence, Brige P Chugh, James Stewart, et al.
International Journal of Radiation Oncology, Biology, Physics|July 9, 2019
Single-Fraction Stereotactic Radiosurgery Versus Hippocampal-Avoidance Whole Brain Radiation Therapy for Patients With 10 to 30 Brain Metastases: A Dosimetric AnalysisTimothy K Nguyen, Arjun Sahgal, Jay Detsky, et al.
Journal of Neuro-Oncology|March 14, 2023
Hypofractionated stereotactic radiosurgery (HSRS) as a salvage treatment for brain metastases failing prior stereotactic radiosurgery (SRS)Michael Yan, Minha Lee, Sten Myrehaug, et al.
Neurosurgery|June 24, 2026
First Report of Staged Adaptive Frameless Stereotactic Radiosurgery in 3 "Pulses" to Salvage Brain Metastases that Failed Previous RadiosurgeryDaniel Tong, Dana Shor, Beibei Zhang, et al.
Journal of Neuro-Oncology|August 30, 2020
Glioma consensus contouring recommendations from a MR-Linac International Consortium Research Group and evaluation of a CT-MRI and MRI-only workflowChia-Lin Tseng, James Stewart, Gillian Whitfield, et al.
International Journal of Radiation Oncology, Biology, Physics|February 23, 2024
Stereotactic Body Radiation Therapy for Sacral Metastases: Deviation From Recommended Target Volume Delineation Increases the Risk of Local FailureDaniel Moore-Palhares, K Liang Zeng, Chia-Lin Tseng, et al.
International Journal of Radiation Oncology, Biology, Physics|November 23, 2024
Spine Stereotactic Body Radiation Therapy in Geriatric Patients: Implications of Age and Dose on Iatrogenic Vertebral Compression Fracture RiskAdrian Wai Chan, Kang Liang Zeng, Daniel Moore-Palhares, et al.
Neurosurgery|April 19, 2023
30 Gy in 4 Stereotactic Body Radiotherapy Fractions for Complex Spinal Metastases: Mature Outcomes Supporting This Novel RegimenDaniel Moore-Palhares, Arjun Sahgal, K Liang Zeng, et al.
Journal of Neurosurgery. Spine|November 7, 2025
Outcomes following stereotactic body radiation therapy specific to spinal metastases with paraspinal disease extension: does volume matter?Wee Loon Ong, Kang Liang Zeng, Daniel Moore-Palhares, et al.
Practical Radiation Oncology|January 7, 2019
Assessing Functionality and Benefits of Comprehensive Dose Volume Prescriptions: An International, Multi-Institutional, Treatment Planning Study in Spine Stereotactic Body Radiation TherapyTomohisa Furuya, Jun H Phua, Mark Ruschin, et al.
Pageof 11

Showing results (81-90 of 107) with videos related to

Sort By:
Pageof 11
Physics and Imaging in Radiation Oncology|December 16, 2025
Magnetic resonance imaging-guided linear accelerator arterial spin labelling reveals dynamics of highly perfused non-enhancing glioblastoma during radiotherapyLiam S P Lawrence, Brige P Chugh, James Stewart, et al.
International Journal of Radiation Oncology, Biology, Physics|July 9, 2019
Single-Fraction Stereotactic Radiosurgery Versus Hippocampal-Avoidance Whole Brain Radiation Therapy for Patients With 10 to 30 Brain Metastases: A Dosimetric AnalysisTimothy K Nguyen, Arjun Sahgal, Jay Detsky, et al.
Journal of Neuro-Oncology|March 14, 2023
Hypofractionated stereotactic radiosurgery (HSRS) as a salvage treatment for brain metastases failing prior stereotactic radiosurgery (SRS)Michael Yan, Minha Lee, Sten Myrehaug, et al.
Neurosurgery|June 24, 2026
First Report of Staged Adaptive Frameless Stereotactic Radiosurgery in 3 "Pulses" to Salvage Brain Metastases that Failed Previous RadiosurgeryDaniel Tong, Dana Shor, Beibei Zhang, et al.
Journal of Neuro-Oncology|August 30, 2020
Glioma consensus contouring recommendations from a MR-Linac International Consortium Research Group and evaluation of a CT-MRI and MRI-only workflowChia-Lin Tseng, James Stewart, Gillian Whitfield, et al.
International Journal of Radiation Oncology, Biology, Physics|February 23, 2024
Stereotactic Body Radiation Therapy for Sacral Metastases: Deviation From Recommended Target Volume Delineation Increases the Risk of Local FailureDaniel Moore-Palhares, K Liang Zeng, Chia-Lin Tseng, et al.
International Journal of Radiation Oncology, Biology, Physics|November 23, 2024
Spine Stereotactic Body Radiation Therapy in Geriatric Patients: Implications of Age and Dose on Iatrogenic Vertebral Compression Fracture RiskAdrian Wai Chan, Kang Liang Zeng, Daniel Moore-Palhares, et al.
Neurosurgery|April 19, 2023
30 Gy in 4 Stereotactic Body Radiotherapy Fractions for Complex Spinal Metastases: Mature Outcomes Supporting This Novel RegimenDaniel Moore-Palhares, Arjun Sahgal, K Liang Zeng, et al.
Journal of Neurosurgery. Spine|November 7, 2025
Outcomes following stereotactic body radiation therapy specific to spinal metastases with paraspinal disease extension: does volume matter?Wee Loon Ong, Kang Liang Zeng, Daniel Moore-Palhares, et al.
Practical Radiation Oncology|January 7, 2019
Assessing Functionality and Benefits of Comprehensive Dose Volume Prescriptions: An International, Multi-Institutional, Treatment Planning Study in Spine Stereotactic Body Radiation TherapyTomohisa Furuya, Jun H Phua, Mark Ruschin, et al.
Pageof 11